Our expertise lies in facilitating the accessibility of BNCT treatment for patients in need. Neuboron, founded in 2014 in Nanjing, China, is the leading provider of comprehensive BNCT solutions, including the development of the accelerator-based BNCT (AB-BNCT) system, treatment planning system, Monte-Carlo based dose engine, and tumor-targeting boron carriers, among others. Neuboron has implemented more than 500 patented and intellectual property protected technologies in its BNCT comprehensive solution.
Neuboron
Headquarters
People's Republic of China